|Last Price||Today's Change||52-Week Range||Trading Volume|
|7.00 CAD||-0.25 (-3.45%)||4.80 - 9.25||1.1 thousand|
Market data as of 2:27PM 11/27/14. Quotes are delayed by at least 15 min.
Transition Therapeutics' ELND005 Showed No Prolongation of QT Interval
PR Newswire - Monday 11/24/2014 6:01 AM ET
Transition Therapeutics Announces Results from ELND005 Clinical Study in Adults with Down Syndrome
PR Newswire - Thursday 11/20/2014 6:01 AM ET
Transition Therapeutics Announces First Quarter Fiscal 2015 Financial Results
PR Newswire - Wednesday 11/12/2014 4:01 PM ET
Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2015 Financial Results on Wednesday, November 12th, at 4:30 P.M. EST
PR Newswire - Monday 11/10/2014 6:01 AM ET
Transition Therapeutics Reports Findings from Bipolar Disorder Phase 2 Study
PR Newswire - Tuesday 11/04/2014 6:01 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.